You have no items in your shopping cart.
Oncology
In this section you will find Therapeutics Diseases Oncology market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities in the biotech, life science and pharmaceutical industries.
| Items 1 to 10 of 120 total | Page: | Show per page |
| View as: List Grid |
Sort by
|
Analytical Tool - Cancer Therapeutic Antibodies
Published by BioSeeker Group on Mar 1st, 2010
€ 3,999.00
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer antibody R&D and business development. Learn More
Antibody Drug Target Atlas in Oncology - Where to Commercialize in a Crowded Market Place?
Published by BioSeeker Group on Mar 1st, 2010
€ 2,450.00
This report comprises defined and up to date development strategies for 441 antibody drugs (993 projects) within the portfolio of 168 investigators, from Ceased to Marketed. The report extensively analyses 225 identified targets of antibody drugs, organized into 234 drug target profiles, and assesses them in 69 different cancer indications. Learn More
Oncology Market Leaders Analyses and Outlook 2010-2025
Published by Visiongain on Jan 25th, 2010
€ 1,713.00
Cancer treatment is a global healthcare priority, one with rising therapeutic and commercial importance. Over 20 million new cases of cancer are predicted in 2025, compared with 12 million in... Learn More
Colorectal Cancer Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 270 (234) companies plus partners developing 330 (270) drugs targeting colorectal cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 141 (110) drugs. Colorectal Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 187 (155) different targets. Learn More
Analytical Tool - Melanoma
Published by BioSeeker Group on Jan 20th, 2010
€ 3,100.00
This report offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in melanoma R&D. Learn More
Analytical Tool - Apoptosis in Oncology
Published by BioSeeker Group on Jan 20th, 2010
€ 3,100.00
In this Analytical Tool, BioSeeker Group brings light and understanding of the whole industrial endeavor in apoptosis as cancer therapeutic mechanism. Learn More
Breast Cancer Drug Pipeline Update 2010
Published by BioSeeker Group on Jan 20th, 2010
€ 1,499.00
There are today 304 (268) companies plus partners developing 417 (360) drugs targeting breast cancer in active development. In addition, the accumulated number of ceased drugs over the last years amount to another 155 (116) drugs. Breast Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 207 (180) different targets. Learn More
Analytical Tool - Breast Cancer
Published by BioSeeker Group on Jan 20th, 2010
€ 3,100.00
The ultimate tool for serious players who would like to understand the current competitive field in breast cancer drug development. Learn More
Analytical Tool - Cancer Vaccines
Published by BioSeeker Group on Jan 20th, 2010
€ 3,100.00
The ultimate tool for serious players who would like to understand the current competitive field in cancer vaccine development. Learn More
Analytical Tool - Angiogenesis in Oncology
Published by BioSeeker Group on Jan 20th, 2010
€ 3,100.00
The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More
| Items 1 to 10 of 120 total | Page: | Show per page |
| View as: List Grid |
Sort by
|